U.K. biotech Immunocor expands in wake of Genentech deal;

 @FierceBiotech:  SEC hunting down traders who made a quick killing on Onyx shares. Report | Follow @FierceBiotech

 @JohnCFierce:  Orexo stakes out $500M market for new opioid-addiction drug. More | Follow @JohnCFierce

 @RyanMFierce:  Xoma staffers form biotech startup to advance blood pressure med. News | Follow @RyanMFierce

 @EmilyMFierce:  In case you missed it over the holiday... Scientists create first regulatory map of tuberculosis. Report | Follow @EmilyMFierce

> Fast on the heels of completing a discovery deal with Genentech, the U.K.'s Immunocore is expanding, adding 25 staffers and a new facility for their work. Story

> Theragenics has signed an agreement to get its brachytherapy seeds into Europe, in an effort to expand its market share as the company considers a buyout worth up to $71.4 million. Story

> The proxy outfit ISS has backed three of First Manhattan's 9 members nominatees to the board of Vivus ($VVUS), where First Manhattan is the largest shareholder and seeks greater control of the company's leadership. Report

> Paris-based Cellectis reported that the company's experimental T-cell therapy killed human leukemia cells that had been implanted in mice. Release

Medical Device News

 @FierceMedDev: Europe tables vote on tougher device regs. More | Follow @FierceMedDev

 @MarkHFierce:  We want your FMD Fierce 15 nominations. Send them in! More | Follow @MarkHFierce

 @DamianFierce: Theragenics has signed a deal to get its brachytherapy products on the market in the EU. Story | Follow @DamianFierce

 @MichaelGFierce: ICYMI: Avanir drops $110M on novel inhaled-delivery migraine device. Article | Follow @MichaelGFierce

>  India's move to modernize its medical device regulations appears close. More

> U.K. playing catch-up with proton-therapy devices. News

Pharma News

 @FiercePharma:  FDA to update generic labeling rules. Article | Follow @FiercePharma

 @CarlyHFierce: ICYMI: Glass particles trigger another Fresenius Kabi recall. Story | Follow @CarlyHFierce

>  Novartis' Lucentis gets its fourth approval in EU. News

> Orexo gets FDA approval for opioid addiction-fighting Zubsolv. Story

> Fresenius gets warning letter for India plant. More

Vaccines News

> Reliance on NIH threatens HIV vaccine funding. Story

> Polio discovery prompts Israeli vaccination push. More

> Merck KGaA: Lung cancer vaccine not dead. Article

> Study: Use of 2D barcodes could save healthcare $300M. News

> Novartis and Sanofi nab DoD vaccine contracts. Item

And Finally… ChemistDirect, a U.K. online pharmacy, has picked up $10 million in new investments from Atomico, Lepe Partners and DMG Media. Item